English | Español
John Breslin | Jul 10, 2017

Rising cost of chronic mental health conditions could hit $3.5 trillion by 2030
Carrie Bradon | Jul 9, 2017

Japanese Ministry of Health, Labor and Welfare approves Olumiant
Caitlin Nordahl | Jul 9, 2017

Practice Fusion EHR receives PCMH Prevalidation
Caitlin Nordahl | Jul 8, 2017

FDA hoping to increase availability of generic drugs
LocalLabs News Service | Jul 7, 2017

AbbVie’s hepatitis C drug pending approval in Europe 
Robert Hadley | Jul 5, 2017

European regulators consider expanding use of Amgen parathyroid drug to young patients
Michael McGrady | Jul 5, 2017

Policy experts weigh in on new executive order on drug pricing
Erianne Leatherman | Jul 2, 2017

Pfizer’s cardiomyopathy drug, tafamidis, on FDA fast track

Trending
+ Community
Patient Daily | Mar 27, 2025

Healthcare professionals recognized at National Breathe Free conference for outstanding dedication
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+ Pharmaceuticals
Patient Daily | Apr 1, 2025

American Lung Association responds to HHS budget cuts
+ Pharmaceuticals
Patient Daily | Apr 1, 2025

Research proposes new strategies for diagnosing and treating Langerhans cell histiocytosis